CHEN, LIXIN – Trademark Portfolio

Entity Type: 01

CHEN, LIXIN has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 2 are successfully registered — a 67% registration rate. The portfolio includes marks such as CILE and WINNROK. Filings span 3 Nice Classification classes, with the highest activity in Class 25 (Clothing) and Class 8 (Hand Tools). This trademark owner is based in HENGYANG, HUNAN.

QINGJIA GROUP, CHASHAN VILLAGE, DONGHU

TOWN,, HENGSHAN COUNTY,

HENGYANG, HUNAN 421300 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

WINNROK
WINNROK
Registered 2022
CILE
CILE
Registered 2020
AMOLUV
AMOLUV
Cancelled 2015

Trademark Classifications

CHEN, LIXIN's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

8
Hand Tools (1 filing)

Hand tools and implements (hand-operated); cutlery; side arms; razors

18
Leather Goods (1 filing)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

Frequently Asked Questions

How many trademarks does CHEN, LIXIN have?

CHEN, LIXIN has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.

What trademark classes does CHEN, LIXIN file in?

CHEN, LIXIN files trademarks across 3 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 8 (Hand Tools), Class 18 (Leather Goods). Class 25 covers clothing, footwear, headgear.

What are CHEN, LIXIN's most well-known trademarks?

CHEN, LIXIN's registered trademark portfolio includes well-known marks such as CILE and WINNROK. These are among 2 currently registered trademarks in the portfolio.

What is CHEN, LIXIN's trademark registration success rate?

CHEN, LIXIN has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.